Newsletter Archive

  1. 06.08.26 -- Smarter Clinical Trials Start With Better Strategy 6/8/2026
    06/08/26 Life Science Leader Newsletter
  2. 06.07.26 -- Repurposed And Derisked Development Candidates As Industry Innovation 6/7/2026
    06/07/26 Life Science Leader Newsletter
  3. 06.05.26 -- Rare Disease Drug Commercialization With Zevra Therapeutics' Neil McFarlane 6/5/2026
    06/05/26 Life Science Leader Newsletter
  4. 06.05.26 -- New Podcast Episodes: Validation Challenges, Rare Disease Drug Commercialization, Redefining CAR-T Timing, and More 6/5/2026
    06/05/26 Life Science Leader Newsletter
  5. 06.04.26 -- Who Are Clinical Trials Really Reaching? 6/4/2026

    06/04/26 Life Science Leader Newsletter

  6. 06.03.26 -- Patient Data Now Has Borders. Does Your Life Sciences Strategy? 6/3/2026
    06/03/26 Life Science Leader Newsletter
  7. 06.01.26 -- Breaking Down Operational And Financial Complexity In Clinical Trials 6/1/2026
    06/01/26 Life Science Leader Newsletter
  8. 05.31.26 -- Dealing With Emerging Data Sovereignty Regulations 5/31/2026
    05/31/26 Life Science Leader Newsletter
  9. 05.29.26 -- Beyond GLP-1s: Competing In The Era Of Consumerized Therapeutics 5/29/2026
    05/29/26 Life Science Leader Newsletter
  10. 05.29.26 -- Guide To Improving Local PV Operations Across Global Markets 5/29/2026

    05/29/26 Life Science Leader Newsletter